Cargando…

C-Reactive Protein Level: A Key Predictive Marker of Cachexia in Lymphoma and Myeloma Patients

BACKGROUND: Cachexia is defined as an involuntary loss of weight, characterized by a loss of skeletal muscle mass with or without fat mass loss. It increases mortality risk and decreases quality of life in patients with lymphoma or myeloma. Early markers of cachexia are not identified. The objective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mallard, Joris, Gagez, Anne-Laure, Baudinet, Cedric, Herbinet, Aline, Maury, Jonathan, Bernard, Pierre Louis, Cartron, Guillaume
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2019
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153683/ https://www.ncbi.nlm.nih.gov/pubmed/32300444 http://dx.doi.org/10.14740/jh536

Ejemplares similares

Drug metabolism and clearance system in tumor cells of patients with multiple myeloma
por: Hassen, Wafa, et al.
Publicado: (2014)

Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells
por: Gourzones, Claire, et al.
Publicado: (2019)

miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study
por: Duroux-Richard, Isabelle, et al.
Publicado: (2022)

O5-1 Physical activity promotion in long term illness patients: Preliminary results on a French national program
por: Robin, Nicolas Salesse A, et al.
Publicado: (2022)

Time for an individualized approach to first-line management of follicular lymphoma
por: Cartron, Guillaume, et al.
Publicado: (2022)

Emerging markers of cancer cachexia and their relationship to sarcopenia
por: Lipshitz, Melanie, et al.
Publicado: (2023)

Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma
por: Go, Se‐Il, et al.
Publicado: (2021)

Emerging markers of cachexia predict survival in cancer patients
por: Mondello, Patrizia, et al.
Publicado: (2014)

Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance
por: Vikova, Veronika, et al.
Publicado: (2019)

Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia
por: Ábrigo, Johanna, et al.
Publicado: (2018)

Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia
por: Delitto, Daniel, et al.
Publicado: (2016)

Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia
por: Morley, John E.
Publicado: (2017)

RNA-Sequencing-Based Transcriptomic Score with Prognostic and Theranostic Values in Multiple Myeloma
por: Alaterre, Elina, et al.
Publicado: (2021)

Revisiting the clinical usefulness of C-reactive protein in the set of cancer cachexia
por: Tavares, Patrícia, et al.
Publicado: (2021)

Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?
por: Caraux, Anouk, et al.
Publicado: (2012)

Targeting the Gut Microbiota to Treat Cachexia
por: Genton, Laurence, et al.
Publicado: (2019)

Inflammation‐induced cholestasis in cancer cachexia
por: Thibaut, Morgane M., et al.
Publicado: (2020)

Comprehensive characterization of the epigenetic landscape in Multiple Myeloma
por: Alaterre, Elina, et al.
Publicado: (2022)

A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment
por: Lamure, Sylvain, et al.
Publicado: (2020)

Kinome expression profiling to target new therapeutic avenues in multiple myeloma
por: de Boussac, Hugues, et al.
Publicado: (2020)

Identification of Cause of Posttransplant Cachexia by PCR
por: Guitard, Joelle, et al.
Publicado: (2012)

Beneficial bacteria inhibit cachexia
por: Varian, Bernard J., et al.
Publicado: (2016)

Cancer cachexia.
por: Tisdale, M. J.
Publicado: (1991)

Cancer cachexia
por: Martignoni, Marcus E, et al.
Publicado: (2003)

Cancer cachexia
por: Dhanapal, Raghu, et al.
Publicado: (2011)

Ghrelin for cachexia
por: Akamizu, Takashi, et al.
Publicado: (2010)

Inflammation in Cachexia
por: Seelaender, M., et al.
Publicado: (2015)

Syphilitic Cachexia
por: Duckworth, Dyce
Publicado: (1908)

Splenic Cachexia
Publicado: (1904)

The Cachexia of Cancer
por: Williams, W. Roger
Publicado: (1897)

Cardiac cachexia
por: Lena, Alessia, et al.
Publicado: (2019)

Malarial Cachexia
por: Gordon, Charles P.
Publicado: (1873)

Differential Diagnosis of Cachexia and Refractory Cachexia and the Impact of Appropriate Nutritional Intervention for Cachexia on Survival in Terminal Cancer Patients
por: Nakajima, Nobuhisa
Publicado: (2021)

Cachexia, a Systemic Disease beyond Muscle Atrophy
por: Wyart, Elisabeth, et al.
Publicado: (2020)

Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers
por: Utech, Anne E., et al.
Publicado: (2012)

miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study
por: Gagez, Anne-Laure, et al.
Publicado: (2017)

Correction: Beneficial bacteria inhibit cachexia
por: Varian, Bernard J., et al.
Publicado: (2018)

Induction of cachexia in mice
por: Tisdale, M
Publicado: (1999)

Treatment of Cachexia in Oncology
por: Tazi, EM, et al.
Publicado: (2010)

Open source in cachexia?
por: Stemmler, Britta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1oj1e6d0ejf8vligeq8omun20h